FDA 510(k)

PoreStar患者特异性植入物

K号: K171037 · 2017-12-27

决定日期2017-12-27

产品代码JOF

咨询委员会医疗设备监管文本描述翻译如下：关于[公司/产品名称]的监管信息： - 美国食品药品监督管理局（FDA）批准号：[510(k)编号] - 预市场批准（PMA）申请号：[PMA编号] - 临床试验注册号（NCT）：[NCT编号] - 医学文献标识符（PMID）：[PMID编号] - 产品标识符：[标识符] - 相关政策：医疗监管政策v1 - 更多信息请访问：[URL] 请注意，以上翻译保留了公司/产品名称、FDA、510(k)、PMA、NCT、PMID、标识符和URL。

决定实质等同

器械摘要

PoreStar Patient Specific Implant is the device name listed in this FDA 510(k) record. The listed applicant is Anatomics Pty, Ltd.. It received FDA 510(k) clearance on 2017-12-27 under 510(k) number K171037. The device is classified under product code JOF. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the PoreStar Patient Specific Implant?

PoreStar Patient Specific Implant is a medical device that received FDA 510(k) clearance on 2017-12-27. The listed applicant is Anatomics Pty, Ltd.. The 510(k) number is K171037.

When did PoreStar Patient Specific Implant receive FDA 510(k) clearance?

PoreStar Patient Specific Implant received FDA 510(k) clearance on 2017-12-27, under 510(k) number K171037.

Who is the listed applicant for PoreStar Patient Specific Implant?

The FDA 510(k) record lists Anatomics Pty, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PoreStar Patient Specific Implant?

The FDA product code for PoreStar Patient Specific Implant is JOF.

列明Anatomics Pty, Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K200532StarPore

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。